1. Home
  2. Analysis
  3. Clofarabine
  4. Oedema-peripheral

Clofarabine and Oedema peripheral - a phase IV clinical study of FDA data

Summary:

Oedema peripheral is reported as a side effect among people who take Clofarabine (clofarabine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Busulfan, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Oedema peripheral when taking Clofarabine. It is created by eHealthMe based on reports of 2,637 people who have side effects when taking Clofarabine from the FDA, and is updated regularly.

What is Clofarabine?

Clofarabine has active ingredients of clofarabine. eHealthMe is studying from 2,644 Clofarabine users. Check the latest studies of Clofarabine.

What is Oedema peripheral?

Oedema peripheral (superficial swelling) is found to be associated with 2,774 drugs and 3,465 conditions by eHealthMe. Check the latest studies of Oedema peripheral.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

2,637 people reported to have side effects when taking Clofarabine.
Among them, 24 people (0.91%) have Oedema peripheral.

Could Clofarabine cause Oedema peripheral?

Among these 24 people:

How long have people been on Clofarabine when they have Oedema peripheral? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Oedema peripheral when taking Clofarabine? *

  • female: 30.43 %
  • male: 69.57 %

What is the age of people who have Oedema peripheral when taking Clofarabine? *

  • 0-1: 0.0 %
  • 2-9: 4.76 %
  • 10-19: 9.52 %
  • 20-29: 4.76 %
  • 30-39: 0.0 %
  • 40-49: 14.29 %
  • 50-59: 4.76 %
  • 60+: 61.9 %

What are other drugs people take besides Clofarabine? *

  1. Busulfan: 7 people, 29.17%
  2. Etoposide: 5 people, 20.83%
  3. Cyclophosphamide: 5 people, 20.83%
  4. Acetaminophen: 4 people, 16.67%
  5. Vancomycin: 4 people, 16.67%
  6. Tacrolimus: 4 people, 16.67%
  7. Ursodiol: 3 people, 12.50%
  8. Melphalan: 3 people, 12.50%
  9. Cytarabine: 3 people, 12.50%
  10. Cyclosporine: 3 people, 12.50%

What are other side effects people have besides Oedema peripheral? *

  1. Diarrhea: 9 people, 37.50%
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 29.17%
  3. Nausea And Vomiting: 6 people, 25.00%
  4. Dyspnea (difficult or laboured breathing): 6 people, 25.00%
  5. Thrombocytopenia (decrease of platelets in blood): 6 people, 25.00%
  6. Pleural Effusion (water on the lungs): 6 people, 25.00%
  7. Hypokalemia (low potassium): 5 people, 20.83%
  8. Atelectasis (partial or complete collapse of the lung): 5 people, 20.83%
  9. Rashes (redness): 5 people, 20.83%
  10. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 4 people, 16.67%

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 25.00%
  2. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 12.50%
  3. Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 8.33%
  4. Precursor B-Lymphoblastic Lymphoma Stage Iv (precursor b-cell cancer stage iv): 1 person, 4.17%
  5. Neoplasm Malignant (cancer tumour): 1 person, 4.17%
  6. Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 1 person, 4.17%
  7. Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 1 person, 4.17%
  8. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 4.17%
  9. B Precursor Type Acute Leukaemia (lymphoid cancer): 1 person, 4.17%
  10. Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Clofarabine and have Oedema peripheral?

- Check whether Oedema peripheral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clofarabine:

Oedema peripheral treatments and more:

How severe was Oedema peripheral and when was it recovered:

Expand to all the drugs that have ingredients of clofarabine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clofarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oedema peripheral:

Browse all the conditions that are associated with Oedema peripheral:

How the study uses the data?

The study uses data from the FDA. It is based on clofarabine (the active ingredients of Clofarabine) and Clofarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.